Schedule 13D ownership disclosure
Madrigal Pharmaceuticals Inc
Security class unavailable · CUSIP: 558868105
Event date: 2020-09-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 18.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-240245
- Form type
- SC 13D
- Filer
- BAY CITY CAPITAL LLC
- CIK
- CIK 1288452
- Filed
- Sep 08, 2020
- Reporting period
- Sep 04, 2020
- Description
- Schedule 13D beneficial ownership